Cebsulfase alfa clinical trials
Also written HGT-1110 and Recombinant human arylsulfatase A.
- studies test it
- 4
- open now
- 0
- in phase 3
- 0
- first study started
- 2007
How each study uses cebsulfase alfa is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
4 studies that test it; most in 2007 (1)
| Year | Studies |
|---|---|
| 2007 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2019 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 4 · Other 0
Studies
Open first, then newest update. How each study uses cebsulfase alfa is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 4
- A Study of Intrathecal SHP611 in Children With Metachromatic LeukodystrophyCompletedPhase 2ShireNCT03771898Written as SHP611
- An Efficacy and Safety Study of HGT-1110 in Participants With Metachromatic LeukodystrophyCompletedPhase 1/2ShireNCT01887938Written as HGT-1110
- Long-term Metazym Treatment of Patients With Late Infantile Metachromatic Leukodystrophy (MLD)CompletedPhase 1/2ShireNCT00633139Written as Recombinant human Arylsulfatase A (rhASA)
- Multicenter Study of HGT-1110 Administered Intrathecally in Children With Metachromatic Leukodystrophy (MLD)CompletedPhase 1/2ShireNCT01510028Written as Recombinant human arylsulfatase A
Codes
What other systems call cebsulfase alfa · ClinicalTrials.gg INT017073
- UNII (FDA) KK93B9NF24CEBSULFASE ALFAOne source FDA
- NCI Thesaurus C190463Cebsulfase AlfaOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | KK93B9NF24 | CEBSULFASE ALFA | One source FDA |
| NCI Thesaurus | C190463 | Cebsulfase Alfa | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.